Covid-19: New York moving over Omicron peak as cases dip sharply

Covid-19's current crisis appears to be mirroring the projections made by officials and health experts that cases in New York are beginning to dip as sharply as they rose around Christmas

Covid, New York, Omicron
IANS New York
2 min read Last Updated : Jan 17 2022 | 9:15 AM IST

Covid-19's current crisis appears to be mirroring the projections made by officials and health experts that cases in New York are beginning to dip as sharply as they rose around Christmas, local media reported Sunday.

New York City Health Department data has shown "very high transmission" of Covid-19 across the city, with thousands of new cases being detected every day, Xinhua news agency reported, citing a leading news site of New York City. However, Covid-19-related infections and hospitalizations have begun to decline, signaling that the five boroughs of the city have passed the peak of the pandemic's biggest wave.

Progress has been seen in the 7-day positivity rates across the five boroughs. Fifty-two areas reported 30 per cent or higher Covid-19 positivity between January 5 and 11, but no area of the city has rates exceeding 40 per cent. During the previous week from December 29 to January 4, the city had 23 areas with 40 per cent or higher positivity rates.

On January 14, the citywide 7-day positivity rate was 27.65 per cent, compared to 32.59 per cent on January 4.

Currently, the only rate that hasn't fallen is the death rate, which has continued to rise due to long-term and more severe Covid-19 infections reported in recent days. As of Jan. 14, the average 7-day death rate was 73, according to the news site.

The unvaccinated remain at a much higher risk of infection, hospitalization, and even death from Covid-19. Health department data shows that unvaccinated New Yorkers are four times as likely to contract Covid-19, eight times as likely to be hospitalised from it, and nine times as likely to die from it than vaccinated New Yorkers, it noted.

--IANS

int/shs

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronCoronavirus Vaccine

First Published: Jan 17 2022 | 9:15 AM IST

Next Story